CAS 83656-38-6

1,2,5-Oxadiazole-3,4-dicarboxamide, N3,N4-bis(1-methylethyl)-, 2-oxide

Description:

1,2,5-Oxadiazole-3,4-dicarboxamide, N3,N4-bis(1-methylethyl)-, 2-oxide, identified by CAS number 83656-38-6, is a heterocyclic organic compound featuring an oxadiazole ring, which is characterized by the presence of nitrogen and oxygen atoms in its structure. This compound typically exhibits properties associated with both amides and oxadiazoles, such as potential solubility in polar solvents and stability under various conditions. The presence of the N,N-bis(1-methylethyl) substituents suggests that it may have enhanced lipophilicity, which could influence its biological activity and interactions. The 2-oxide functional group indicates the presence of an oxygen atom bonded to the carbon atom in the oxadiazole ring, potentially affecting its reactivity and stability. Compounds of this nature are often studied for their applications in pharmaceuticals, agrochemicals, and materials science due to their unique structural features and potential bioactivity. However, specific characteristics such as melting point, boiling point, and spectral data would require further investigation or reference to detailed chemical databases.

Formula: C₁₀H₁₆N₄O₄

InChI: InChI=1S/C10H16N4O4/c1-5(2)11-9(15)7-8(14(17)18-13-7)10(16)12-6(3)4/h5-6H,1-4H3,(H,11,15)(H,12,16)

InChI key: InChIKey=JSKUFGFVEPNZDX-UHFFFAOYSA-N

SMILES: C(NC(C)C)(=O)C=1C(C(NC(C)C)=O)=N(=O)ON1

Synonyms:

• 1,2,5-Oxadiazole-3,4-dicarboxamide, N,N′-bis(1-methylethyl)-, 2-oxide
• 1,2,5-Oxadiazole-3,4-dicarboxamide, N³,N⁴-bis(1-methylethyl)-, 2-oxide
• C 80-1324
• Furazandicarboxamide, N,N′-bis(1-methylethyl)-, 2-oxide
• Ipramidil [INN]
• Ipramidilum
• Ipramidilum [Latin]
• N,N'-di(propan-2-yl)-1,2,5-oxadiazole-3,4-dicarboxamide 2-oxide
• N,N-Diisopropyl-3,4-furazandicarboxamide 2-oxide
• Unii-9Zpc9768Eh
• Ipramidil

Ipramidil

CAS: 83656-38-6

Ipramidil is a pharmaceutical drug that has been used to treat cardiac arrhythmia and ventricular dysfunction. It is a soluble guanylate cyclase activator that increases the level of cGMP in cardiac and vascular cells, which leads to an increase in blood flow. Ipramidil has been shown to be effective at treating symptoms of congestive heart failure by improving the contractility of the heart muscles and increasing blood flow through the body. Ipramidil may also be used as a diagnostic aid for fatty acid metabolism, as hydrogen tartrate is one of its major excipients. Reconstituted ipramidil tablets are administered orally or intravenously. The recommended dose is 1mg/kg (2mg/kg for patients with congestive heart failure).

Formula: C₁₀H₁₆N₄O₄

Purity: Min. 95%

Molecular weight: 256.26 g/mol

Ref: 3D-IDA65638

Ipramidil

CAS: 83656-38-6

Ipramidil (C80-1324) reveals marked dilator activity in the coronary circulation of isolated working hearts.

Formula: C₁₀H₁₆N₄O₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 256.26

Ref: TM-T13588